SUMMARY A case-control study was performed to verify the association between the risk factors for cerebrovascular disease and the syndrome of ventricular enlargement with gait apraxia (VEGAS). This syndrome was defined on the basis of clinical and CT criteria alone; however, it may be representative ofpatients with idiopathic normal pressure hydrocephalus in whom gait disturbance is the initial symptom. Seventeen patients were matched for age and sex with one hospitalised and two general population controls. Among the risk factors considered we found a significant statistical association between VEGAS and hypertension (odds ratio = 3 14; p = 0O032), ischaemic heart disease (odds ratio = 4 20; p = 0-013), ECG ischaemic changes (odds ratio = 3-67; p = 0029), low HDL-cholesterol levels (odds ratio = 3-75; p = 0028) and diabetes (odds ratio = 600; p = 0 018). 
Normal pressure hydrocephalus (NPH) is characterised by a clinical triad (gait disturbance, impairment of mental function and sphincteric incontinence) associated with neuroimaging findings of nonobstructive ventricular enlargement. Reversal of the symptomatology by a shunt is another important feature.Ǹ PH has been traditionally divided into secondary and idiopathic forms. 5 The former is related to head trauma' meningitis or subarchnoid hemorrhage but the aetiology and pathogenesis of idiopathic normal pressure hydrocephalus (INPH) remain uncertain.
The pathogenesis of INPH has traditionally been attributed to a low-grade asymptomatic meningeal disease causing meningeal thickening over the convexity of the cerebral hemispheres and resulting in reduced CSF reabsorption.6 A chronic inflammatory meningeal disease has been hypothesised,6 but not proved. A correlation between INPH and cerebrovascular disease has been proposed,7 based on anatomopathological and clinical correlations. Cerebrovascular changes have been reported in eight out of ten cases studied pathologically;'-" these changes mainly consisted ofatherosclerosis ofcerebral vessels, lacunar and cystic infarctions, microinfarctions, concentric hypertrophy, hyalinosis and fibrinoid necrosis of the small intraparenchymal arteries, arteriolar and capillary sclerosis and demyelination areas.
Clinical correlates ofINPH have included hypertension, 9'012-14 diabetes,7" heart disease,78 obesity, '7 and cerebrovascular disease.781014 Graff-Radford and Godersky'2 recently stressed the association between INPH and hypertension. Earnest et a17 described in detail two patients with INPH who showed gross pathological findings typical of cerebrovascular disease (but no fibrosis) and numerous old microscopic bilateral infarctions in the basal ganglia (clinically asymptomatic). On the basis of these findings they hypothesised that hypertensive vascular disease with multiple deep cerebral infarctions may be the initial pathological process in some cases of INPH, acting through a reduction of tissue bulk and tensile strength of the periventricular white matter and basal ganglia, together with an increased intraventricular CSF pulse pressure due to hypertension. In order to investigate 847 Casmiro, D'Alessandro, Cacciatore, Daidone, Calbucci, Lugaresi this hypothesis we performed a case-control study aimed at verifying if risk factors for cerebrovascular disease were also risk factors for INPH.
Methods
Cases: Diagnostic criteria The cases had to satisfy the following diagnostic criteria: (a) A clinical picture of INPH (gait disturbance with or without impairment of mental function and urinary incontinence) and as the first symptom a gait disturbance characterised by shortened steps, slowed rate of steppage and scuffing feet, widened base and frequent falling (so-called "gait apraxia").3 Impairment of mental function was assessed on the Blessed dementia scale;'5 (b) A CT scan showing (1) dilatation of the ventricular system without obstruction, (2) obliteration of the cerebral sulci at the convexity, (3) areas of periventricular low density and (4) "rounding" of the frontal horns of the lateral ventricles.'6 We excluded patients whose clinical history suggested a possible aetiology for NPH (head trauma, meningitis and subarachnoid haemorrhage).
Cases: inclusion criteria To avoid possible bias we included in the study all patients consecutively admitted between December 1986 and February 1988 because of a gait disturbance, provided that the gait disturbance was the primary reason for seeking medical care. We therefore excluded from the study patients affected by gait disturbance but primarily seen for other neurological or non-neurological symptoms (such as TIAs, myocardial infarction).
Controls
Each case was paired to three controls, matched for sex and age (an age range of ± 3 years, with respect to each case, was chosen). One of these controls was represented by every next patient admitted because ofa neurological disease not known to be related to the risk factors for cerebrovascular disease. Diagnoses ofthese hospitalised controls are shown in table 1. Each ofthese subjects underwent CT. The two other controls were randomly chosen among the general population of Bologna, using the General Registry Office lists. These subjects were contacted by telephone and asked to come forward for a free medical examination. Agreement was about 70%. The protocol required the exclusion from general population controls of those subjects who suffered from gait disturbance, since for ethical reasons we did not perform CT in this population group. However, nobody had to be excluded for this reason.
Riskfactors
The following risk factors were evaluated: Hypertension: blood pressure values exceeding 160 and/or 95 mm Hg on at least three different measurements, or treatment with antihypertensive drugs, irrespective of blood pressure values; Ischaemic heart disease: documented previous clinical admissions for myocardial ischaemic disease; Ischaemic ECG changes: at the time of examination both cases and controls had a standard ECG record. Each ECG was evaluated independently by two "blind" expert cardiologists, and only concordant reports of ischaemic myocardial changes were accepted; HDL-cholesterol levels: -+-} = Matched quadruplets with risk factor absent in case and present in o control.
-+-} = Matched quadruplets with risk factor absent in case and present in toe controls.
-+ ++ = Matched quadruplets with risk factor absent in case and present in three controls. Riskfactorsfor the syndrome of ventricular enlargement with gait apraxia and are limited to the general statement of a clinical triad ("a slowly progressive gait disorder, impairment of mental function and sphincteric incontinence"). 2 The triad is not always present. Thus, the gait disturbance, may be the only obvious symptom'72' and, although the features are often of the so-called "gait apraxia",35 it has also been described as "spasticity"5 or even as a Parkinsonian feature. 2223 Further studies are needed of the mechanism by which cerebrovascular disease contributes to the development of this syndrome. If our findings are confirmed, future studies should be developed to verify whether optimal treatment of risk factors may improve the course of the disease. In any case, neurologists examining such patients will be aware of the need to screen them for potentially dangerous cardiovascular diseases.
